[1. Klečka J, Holubec L, Pešta M, Hora M, Topolčan O, Eret V. Nádorové markery karcinómu prostaty. Ces Urol 2008; 12(3): 173-185.]Search in Google Scholar
[2. Sigebara K, Miyagi T, Nakashima T, Shimamura M. Acute bacterial prostatitis after transrectal nedele biopsy: clinical analysis. J Clin Chemother 2008; 14: 40-43.]Search in Google Scholar
[3. Webb NR, Woo HH. Antibiotic prophylaxis for prostate biopsy. BJU International 2002; 89: 824-828.10.1046/j.1464-410X.2002.02735.x]Search in Google Scholar
[4. EAU Guidelines 2013; Prostate cancer; 6. p: 18.]Search in Google Scholar
[5. Ecke TH, Gunia S, Bartel P, Hallmann S, Koch S, Ruttloff J. Complications and risk factors of transrectal ultrasound guided nedele biopsies of the prostate evaluated by questionnaire. Urol Oncol 2008; 26: 474-478.10.1016/j.urolonc.2007.12.003]Search in Google Scholar
[6. Sieber P, Rommel F, Theodoran C. Contemporary prostate biopsy complication rates in community-based urology practice. Urology 2007; 70(3): 498-500.10.1016/j.urology.2007.04.019]Search in Google Scholar
[7. Ghani K, Dundas D, Patel U. Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7- day morbidity after a six, eight and 12-core biopsy protocol. BJU Int 2004; 94(7): 1014-1020.10.1111/j.1464-410X.2004.05096.x]Search in Google Scholar
[8. Raaijmakers R, Kirkels WJ, Roobol MJ. Complication rates and risc factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002; 60: 826-830.10.1016/S0090-4295(02)01958-1]Search in Google Scholar
[9. Javorka K jr., Švihra J, Ľupták J, Eliáš B, Kliment J. Hodnotenie kvality života po transrektálnej biopsii prostaty pod ultrazvukovou kontrolou a jej komplikácie. Klinická onkologie 2000; 139: 758-761.]Search in Google Scholar
[10. Peyromaure M, Ravery V, Messas A, Toublanc M, Boccon-Gibod L. Pain and morbidity of an extensive prostate 10-biopsy protocol: a prospective study in 289 patients. J Urol. 2002; 167(1): 218-221.10.1016/S0022-5347(05)65416-X]Search in Google Scholar
[11. Collins GN, Lloyd SN, Hehir M, McKelvie GB. Multiple transrectal ultrasound-guided prostatic biopsies-true morbidity and patient acceptance. BJ Urol 1993; 71: 460-463.10.1111/j.1464-410X.1993.tb15993.x]Search in Google Scholar
[12. Kirkels WJ, Rietbergen JBW, Boeken Kruger AE, Kranse R, Schroder FH. Complication rates and risk factors of ultrasound-guided transrectal core biopsies of the prostate in a population based screening program. J Urol 1997; 146: 75-77.]Search in Google Scholar
[13. Kreutzer N, Wolter S, Haupt G, Engelmann U. Schmerzwahrnehmung und Komplikationen bei der transrektalen Prostatabiopsie. Aktuel Urol 2012; 33: 277-282.10.1055/s-2002-32835]Search in Google Scholar
[14. Zisman, A., Leibovici, D., Siegel, Y.I., Lindner, A. Complications and Quality of Life Impairment After Ultrasound Guided Prostate Biopsy - A Prospective Study 1999 Selected Abstracts from American Urological Association annual meeting.10.1097/00005392-199904020-00288]Search in Google Scholar
[15. Pushkar’ Dlu., Govorov A.V. Complications of transrectal biopsy of the prostate. Urology 2005; 112(2): 40-42.]Search in Google Scholar
[16. Paul R, Scholer S, van Randenborgh H. Morbidity of prostatic biopsy for different biopsy strategies: is there a relation to core number and sampling region? Eur Urology 2004; 45: 450-456.]Search in Google Scholar
[17. Naughton CK. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: Impact on cancer detection. J Urol 2000; 163: 168-171.10.1016/S0022-5347(05)67996-7]Search in Google Scholar
[18. Lugg J, Lettieri J, Stass H, Agarwal V. Determination of the concentration of ciprofloxacin in prostate tissue following administration of a single, 1000 mg, extended-release dose. J Chemother 2008; 20: 213-218.10.1179/joc.2008.20.2.21318467248]Search in Google Scholar
[19. Lindstedt S, Lindstrom U, Ljunggren E, Wullt B, Grabe M. Single-dose antibiotic prophylaxis in core prostate biopsy: Impact of timing and identification of risk factors. Eur Urol 2006; 50: 832-837.10.1016/j.eururo.2006.05.00316750292]Search in Google Scholar
[20. Tobias-Machado M, Correa TD, De Baros EL, Wroclawski ER. Antibiotic prophylaxis in prostate biopsy. A comperative randomized clinical assay between ciprofloxacin, norfloxacin and chloramphenicol. Int Braz J Urol 2003; 29(4): 313-319.10.1590/S1677-55382003000400005]Search in Google Scholar
[21. Aron M, Rajeen TP, Gupta NP. Antibiotic prophylaxis for transrectal nedele biopsy of the prostate: a randomized controlled study. BJU Int 2000; 85: 492-494.]Search in Google Scholar
[22. Larsson P, Norming U, Tornblom M, Gustafsson O. Antibiotic prophylaxis for prostate biopsy: benefits and costs. Prostate Cancer Prostatic Dis. 1999; 2: 88-90.10.1038/sj.pcan.450029412496844]Search in Google Scholar
[23. Schaeffer AJ, Montorsi F, Scattoni V, Perroncel R, Song J, Haverstock DC, Pertel PE. Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal nedele biopsy of the prostate. BJU Int 2007; 100: 51-57.10.1111/j.1464-410X.2007.06848.x17552953]Search in Google Scholar